# Progesterone Supplementation in Threatened Abortion

> **NCT03930212** · PHASE4 · COMPLETED · sponsor: **Tanta University** · enrollment: 190 (actual)

## Conditions studied

- Threatened Abortion
- Progesterone Resistance

## Interventions

- **DRUG:** Progesterone
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03930212
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 190 (ACTUAL)
- **Last updated:** 2023-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03930212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03930212, "Progesterone Supplementation in Threatened Abortion". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03930212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*